Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

Condition:   Healthy Interventions:   Drug: Clopidogrel 75mg;   Drug: Tegoprazan 50 mg;   Drug: RAPA113 Sponsor:   CJ HealthCare Corporation Recruiting

Source: ClinicalTrials.gov - November 21, 2019 Category: Research Source Type: clinical trials